Physician profile
Callie E Crider
NPI 1083059273
$4,035.06
in general payments reported to CMS, 2019-2025
44 companies · $454 in 2025
The $454 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $734 · 2020: $440 · 2021: $699 · 2022: $754 · 2023: $582 · 2024: $372 · 2025: $454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,408.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $539.83 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Aspira Women'S Health INC | $270.54 | 2022-2024 | Ova1 |
| Exeltis, USA INC. | $270.09 | 2020-2025 | Slynd |
| Merck Sharp & Dohme LLC | $264.60 | 2019-2024 | Gardasil, Gardasil 9 |
| Astellas Pharma US INC | $250.55 | 2023-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $193.39 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $163.88 | 2023-2025 | Myfembree |
| Hologic Sales and Service, LLC | $159.58 | 2019-2025 | Aptima, Thinprep 2000 Processor, Myosure Tissue Removal Device |
| Evofem Biosciences, INC. | $154.58 | 2021-2022 | |
| Therapeuticsmd, INC. | $142.70 | 2019-2022 | |
| Mylan Pharmaceuticals INC. | $123.39 | 2020-2022 | |
| Organon LLC | $119.80 | 2021-2023 | Nexplanon |
| Sage Therapeutics, LLC | $114.77 | 2019-2025 | Zurzuvae |
| Channel Medsystems, INC. | $107.26 | 2022 | |
| Pfizer INC. | $92.41 | 2019-2023 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lsi Solutions INC | $88.49 | 2021-2023 | Fornisee |
| Baxter Healthcare | $76.79 | 2019-2024 | Perclot |
| Daiichi Sankyo INC. | $67.80 | 2019-2024 | Injectafer |
| Dexcom, INC. | $64.94 | 2024-2025 | Dexcom G6 Transmitter |
| Vertex Pharmaceuticals Incorporated | $57.31 | 2024-2025 | |
| Heron Therapeutics, INC. | $54.67 | 2022-2023 | Zynrelef |
| Myovant Sciences INC. | $53.92 | 2022 | |
| Conmed Corporation | $52.50 | 2019 | |
| Exact Sciences Corporation | $46.73 | 2023-2025 | Cologuard Collection Kit |
| Alydia Health | $44.15 | 2021 | |
| Optumhealth Care Solutions, LLC | $41.96 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Convatec INC. | $34.89 | 2019-2023 | |
| Minerva Surgical, INC | $33.93 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.64 | 2019-2020 | |
| Molnlycke Health Care US, LLC | $28.78 | 2023 | Mepilex Border Post-Op Ag |
| Coopersurgical, INC. | $26.07 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $23.93 | 2025 | Qelbree |
| Pacira Pharmaceuticals Incorporated | $23.68 | 2023 | Exparel |
| Avanos Medical | $23.57 | 2019 | |
| Amag Pharmaceuticals, INC. | $23.14 | 2019-2020 | |
| Medtronic, INC. | $21.98 | 2023 | Ligasure |
| Kowa Pharmaceuticals America, INC. | $21.88 | 2023 | Seglentis |
| Smith+Nephew, INC. | $21.17 | 2022 | |
| Roche Diagnostics Corporation | $21.06 | 2019 | |
| Trevena, INC. | $20.59 | 2021 | |
| Allergan, INC. | $16.70 | 2019 | |
| Alexion Pharmaceuticals, INC. | $15.61 | 2021 | |
| Covidien LP | $15.43 | 2020 | |
| Vertical Pharmaceuticals, LLC | $12.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Callie Crider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.